Patni Rajiv 4
4 · REATA PHARMACEUTICALS INC · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Patni Rajiv
EVP, Chief R&D Officer
Transactions
- Award
Class A common stock
2023-06-12+45,000→ 45,000 total - Award
Employee Stock Option (right-to-buy)
2023-06-12+90,000→ 90,000 totalExercise: $99.12Exp: 2033-06-12→ Class A common stock (90,000 underlying)
Footnotes (2)
- [F1]The shares represent Restricted Stock Units, which vest as to 11,250 shares on June 12, 2024, with the remainder to vest in twelve equal quarterly installments thereafter, subject to continued service through each vesting date.
- [F2]The option, representing a right to purchase a total of 90,000 Class A shares, become exercisable as to 22,500 on June 12, 2024, with the remainder to vest in twelve equal quarterly installments thereafter, subject to continued service through each vesting date.